LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Erba Mannheim Showcases Exciting New Introductions at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 22 Jun 2021
Illustration
Illustration
Erba Mannheim (London, UK) showcased some of its exciting new introductions at MEDLAB Middle East 2021, the MENA region’s largest medical laboratory exhibition and congress, which took place at the Dubai World Trade Centre from 21-24 June.

Erba introduced the fully automated ELAN 30s, a complete solution for lab ELISA workflow that allows users to develop new, flexible analytical workflows by taking advantage of smart scheduling software. By combining up to six different assays in a single run users can break the traditional two or four plate mold and create ‘clinical panel’ based workflows. Multiple reporting formats enhance the final steps of the process and allow the user to report faster with more convenience.

Erba also exhibited its new hematology analyzers - the H360 automated 3 part differential analyzer and H560 automated 5 part differential hematology analyzer, alongside the Elite 580 automated 5-part hematology analyzer with continuous loading capacity. Also on display at this year’s MEDLAB Middle East 2021 edition was the LAURA XL fully automated urine analyzer that combines urine strip reading with digital microscopy. The two-module integrated station consists of one module which performs analysis of the chemical parameters of urine on diagnostic test strips using reflective photometry; and one module performs urinary sediment examination using automated microscopy technology in a format compatible with manual microscopy. In addition, Erba showcased the next generation electrolyte analyzer, EC 90 ISE, which employs cutting edge technology to take laboratory electrolyte measurements to new heights. The EC 90 electrolyte analyzer features next generation thick film, maintenance-free electrodes in all-in-one sensor cartridge.

Alongside these new products, the company presented the ErbaMDx SARS-COV-2 RT-PCR kit, a molecular diagnostic test that aids the detection and diagnosis of COVID-19 infections and is based on latest nucleic acid amplification technologies. It is a real-time reverse transcriptase PCR test that has been developed utilizing universally trusted priming sites with updated primer sequences to maximize long term performance.

Related Links:
Erba Mannheim

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Gold Member
Collection and Transport System
PurSafe Plus®

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more